Literature DB >> 19128829

Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.

Lin Li1, Xu-Ping Liu, Ling Nie, Ming-Hua Yu, Yue Zhang, Tie-Jun Qin, Zhi-Jian Xiao.   

Abstract

Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms. Chromosomal abnormalities have been detected in 40-70% patients with primary MDS and are heterogeneous among patients of different races and from different backgrounds. In the current study, 351 Chinese adult patients with primary MDS were retrospectively analyzed for their chromosomal abnormalities by karyotyping. Among the 237 cases (67.5%) of chromosomal abnormalities, 99 were copy number changes alone (41.7%), 70 were structural abnormalities alone (29.5%), and 68 displayed both of these changes (28.8%). Overall, the frequency of -5/5q-/del(5)(q13-33) was 5.1% in these Chinese MDS patients, which was lower than that in the MDS patients of western countries (8.7-23.4%), and the incidence of 5q- syndrome was only 0.3% in Chinese MDS patients. On the other hand, the frequencies of trisomy 8 (19.1%) and -20/20q-/del(20)(q11-13) (9.4%) were higher than those in western countries (1.2-7.0% and 2.0-3.5%, respectively). Chromosomal translocations were also detected in 31 cases (13.1%) including 12 rare translocations that have not been reported in MDS patients before. In addition, i(17)(q10) was detected in nine cases (3.8%), of which six cases only had this single abnormality. According to the IPSS chromosomal prognostic classification, the incidence of poor-risk karyotypes increased in the advanced WHO subtypes (p < 0.001). Together, we detected the unique cytogenetic features of chromosomal abnormalities and some rare translocations of MDS among Chinese patients.

Entities:  

Mesh:

Year:  2009        PMID: 19128829     DOI: 10.1016/j.leukres.2008.11.021

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Features of Japanese patients with myelodysplastic syndrome in an aging population of Sado Island.

Authors:  Kumiko Yagisawa; Kiyoshi Okazuka; Ken Toba; Masaru Urushiyama; Takashi Kuroha; Noriko Izumi; Yasuhiko Sibasaki; Masutaka Higashimura; Toshio Yano; Akihito Momoi; Akira Hattori; Ken Momotsu; Yoshifusa Aizawa
Journal:  Int J Hematol       Date:  2012-02-24       Impact factor: 2.490

Review 2.  Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Authors:  Stephanie Beurlet; Christine Chomienne; Rose Ann Padua
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

3.  A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon.

Authors:  Zaher K Otrock; Nabil Chamseddine; Ziad M Salem; Tarek Wehbe; Mouna Al-Ayoubi; Moussa Dhaini; Joseph Kattan; Walid Mokaddem; Therese Abi Nasr; Oussama Jradi; Fadi S Farhat; Mahmoud Wehbe; Mohammad H Haidar; Mohamed A Kharfan-Dabaja; Nizar Bitar; Mirna El Hajj; Adel M Kadri; Francois G Kamar; Hanan Yassine; Hassan Khodr; Ali T Taher; Noha Hakime; Rami Ar Mahfouz; Wassim Serhal; Ali Bazarbachi; Hussein Z Farhat
Journal:  Am J Blood Res       Date:  2015-12-25

4.  Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients.

Authors:  Mostafa Paridar; Kazem Zibara; Seyed Esmaeil Ahmadi; Abbas Khosravi; Maral Soleymani; Ebrahim Azizi; Omid Kiani Ghalesardi
Journal:  Mol Cytogenet       Date:  2021-05-08       Impact factor: 2.009

5.  Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.

Authors:  Jingya Wang; Xiaofei Ai; Tiejun Qin; Zefeng Xu; Yue Zhang; Jinqin Liu; Bing Li; Liwei Fang; Hongli Zhang; Lijuan Pan; Naibo Hu; Shiqiang Qu; Wenyu Cai; Kun Ru; Yujiao Jia; Gang Huang; Zhijian Xiao
Journal:  Oncotarget       Date:  2017-01-03

6.  Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes.

Authors:  Minh Phuong Vu; Hong Quang Ha; Cuc Nhung Nguyen
Journal:  Leuk Res Rep       Date:  2022-08-12

7.  Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromes.

Authors:  Xiao Li; Zhi-jian Xiao; Chun-kang Chang; Feng Xu; Ling-yun Wu; Qi He; Ze-feng Xu; Lu-xi Song; Zheng Zhang; Li-yu Zhou; Ji-ying Su; Xi Zhang; Juan Guo
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 8.  Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2013-10-07

9.  Clinical Prognostic Factors in 86 Chinese Patients with Primary Myelodysplastic Syndromes and Trisomy 8: A Single Institution Experience.

Authors:  Qing Fang Yue; Lei Chen; Xiao Mei She; Bin Hu; Yu Hu; Ping Zou; Xin Yue Liu
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

10.  Cytogenetic features in primary myelodysplastic syndrome Egyptian patients.

Authors:  Yasser Elnahass; Lamiaa Youssif
Journal:  J Adv Res       Date:  2018-02-07       Impact factor: 10.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.